• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

2
2
3
7

PUBLISHED

1
1
4
7

PRODUCT TYPE

5
2

Search "Herpes zoster infections Therapy Area Pipeline Report" returned 7 results.

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015 Summary This, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015’, provides an overview of the Varicella Zoster (HHV-3)...

April 2015
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

August 2015
FROM

Global Herpes Market 2014-2018

About Herpes Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area...

December 2014
FROM

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

June 2009
FROM

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories: - Glaucoma - Anti-allergy - Anti-infective - Dry Eye - Anti-inflammation...

October 2010
FROM

Depomed, Inc. (DEPO) - Financial and Strategic SWOT Analysis Review

Depomed, Inc. (DEPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

April 2015
FROM

Inhibitex, Inc. (INHX) - Financial and Strategic Analysis Review

Inhibitex, Inc. (Inhibitex) is a development stage biopharmaceutical company engaged in the research and development of innovative products for the treatment of serious infectious diseases. The pipeline...

July 2010
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation